Rothschild & CO Wealth Management Uk LTD Pfizer Inc Transaction History

Rothschild & CO Wealth Management Uk LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2017 Dec 19, 2019	SELL	N/A	-8,179 Closed	0 $0
Q1 2017 Dec 19, 2019	BUY	N/A	8,179 New	8,179 $280,000
Q1 2016 Dec 19, 2019	SELL	N/A	-657 Closed	0 $0
Q4 2015 Dec 19, 2019	BUY	N/A	657 New	657 $21,000
Q3 2015 Dec 19, 2019	SELL	N/A	-6,536 Closed	0 $0
Q2 2015 Dec 19, 2019	SELL	N/A	-17,564 Reduced 72.88%	6,536 $219,000
Q1 2015 Dec 19, 2019	BUY	N/A	18,100 Added 301.67%	24,100 $838,000
Q1 2014 Dec 19, 2019	BUY	N/A	6,000	6,000 $193,000

3,247

3.72B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Rothschild & CO Wealth Management Uk LTD, based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Wealth Management Uk LTD with notifications on news.